Bipolar pharmacotherapy and suicidal behavior. Part 3: Impact of antipsychotics

Boghos I. Yerevanian, Ralph J. Koek, Jim Mintz

Resultado de la investigación: Articlerevisión exhaustiva

34 Citas (Scopus)


Introduction: Antipsychotics, particularly second generation agents, are widely used in bipolar disorder, but their effect on suicidal behavior in this population has not been systematically studied. Methods: Retrospective chart review of 405 veterans with bipolar disorder followed for a mean of three years, with month-by-month systematic assessment of current pharmacotherapy and suicide completion, attempt or hospitalization for suicidality. Comparison of rates of suicidal events during mood stabilizer monotherapy, antipsychotic monotherapy, and combination of mood stabilizer and antipsychotic. Results: Non-lethal suicide event rates were 9.4 times greater (χ2 = 28.29, p < .0001) during antipsychotic monotherapy and 3.5 times greater during mood stabilizer + antipsychotic (χ2 = 15.13, p = 0.0001) than during mood stabilizer monotherapy. Limitations: Antipsychotics may have been prescribed because patients were at greater risk of suicidal behavior. First and second generation antipsychotics were not distinguished. Conclusions: Treatment of bipolar patients with antipsychotics is associated with an increase in non-lethal suicidal behavior. Thus, use of antipsychotics for bipolar patients requires careful monitoring for suicidal behavior. Further studies are urgently needed to better characterize this relationship.

Idioma originalEnglish (US)
Páginas (desde-hasta)23-28
Número de páginas6
PublicaciónJournal of Affective Disorders
EstadoPublished - nov. 2007
Publicado de forma externa

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health


Profundice en los temas de investigación de 'Bipolar pharmacotherapy and suicidal behavior. Part 3: Impact of antipsychotics'. En conjunto forman una huella única.

Citar esto